Optimization of ultrasound-assisted extraction of ascorbic acid from fennel (Foeniculum vulgare) seeds and evaluation its extracts in free radical scavenging

The main objective of this study was to compare ultrasound assisted extraction with soxhlet extraction method as control in the extraction ascorbic acid of fennel seeds. Treatment conditions were performed using soxhlet method (240 min at 85 °C) and ultrasound treatment (20 kHz, 39, 64 and 96 W/cm2, 40 and 60 °C), for 15, 30 and 45 min. No significant differences were observed for total soluble solids among the samples studied. A similar trend was observed for both the amount of ascorbic acid extract and its ability to DPPH free radical scavenging. The greatest amount of ascorbic acid obtained in 15 minutes sonication (96 W/cm2 at 60 °C), with equivalent of 1.73 mg/ml fennel seeds extraction. There was a significant difference between soxhlet and ultrasound method, which caused an increase of 69.94 mg/ml ascorbic acid in the extraction compared to the soxhlet. The highest percentage of hydrogen peroxide scavenging was observed in 15 min sonication (96 W/cm2 at 60 °C) equivalent to 74.13% without any significant difference with soxhlet method (6.93% increase in free radical). The highest percentage of DPPH free radical scavenging was observed in 15 min sonication (96 W/cm2 at 60 °C) equivalent to 98.88% without any significant difference with soxhlet method (0.18% increase in free radical). The results of the present study demonstrate that ultrasound assisted extraction is an alternative affordable for yield extraction compared to soxhlet method

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

Background: Future trends in disease burden and drivers of health are of great interest to policy makers and the public at large. This information can be used for policy and long-term health investment, planning, and prioritisation. We have expanded and improved upon previous forecasts produced as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) and provide a reference forecast (the most likely future), and alternative scenarios assessing disease burden trajectories if selected sets of risk factors were eliminated from current levels by 2050. Methods: Using forecasts of major drivers of health such as the Socio-demographic Index (SDI; a composite measure of lag-distributed income per capita, mean years of education, and total fertility under 25 years of age) and the full set of risk factor exposures captured by GBD, we provide cause-specific forecasts of mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) by age and sex from 2022 to 2050 for 204 countries and territories, 21 GBD regions, seven super-regions, and the world. All analyses were done at the cause-specific level so that only risk factors deemed causal by the GBD comparative risk assessment influenced future trajectories of mortality for each disease. Cause-specific mortality was modelled using mixed-effects models with SDI and time as the main covariates, and the combined impact of causal risk factors as an offset in the model. At the all-cause mortality level, we captured unexplained variation by modelling residuals with an autoregressive integrated moving average model with drift attenuation. These all-cause forecasts constrained the cause-specific forecasts at successively deeper levels of the GBD cause hierarchy using cascading mortality models, thus ensuring a robust estimate of cause-specific mortality. For non-fatal measures (eg, low back pain), incidence and prevalence were forecasted from mixed-effects models with SDI as the main covariate, and YLDs were computed from the resulting prevalence forecasts and average disability weights from GBD. Alternative future scenarios were constructed by replacing appropriate reference trajectories for risk factors with hypothetical trajectories of gradual elimination of risk factor exposure from current levels to 2050. The scenarios were constructed from various sets of risk factors: environmental risks (Safer Environment scenario), risks associated with communicable, maternal, neonatal, and nutritional diseases (CMNNs; Improved Childhood Nutrition and Vaccination scenario), risks associated with major non-communicable diseases (NCDs; Improved Behavioural and Metabolic Risks scenario), and the combined effects of these three scenarios. Using the Shared Socioeconomic Pathways climate scenarios SSP2-4.5 as reference and SSP1-1.9 as an optimistic alternative in the Safer Environment scenario, we accounted for climate change impact on health by using the most recent Intergovernmental Panel on Climate Change temperature forecasts and published trajectories of ambient air pollution for the same two scenarios. Life expectancy and healthy life expectancy were computed using standard methods. The forecasting framework includes computing the age-sex-specific future population for each location and separately for each scenario. 95% uncertainty intervals (UIs) for each individual future estimate were derived from the 2·5th and 97·5th percentiles of distributions generated from propagating 500 draws through the multistage computational pipeline. Findings: In the reference scenario forecast, global and super-regional life expectancy increased from 2022 to 2050, but improvement was at a slower pace than in the three decades preceding the COVID-19 pandemic (beginning in 2020). Gains in future life expectancy were forecasted to be greatest in super-regions with comparatively low life expectancies (such as sub-Saharan Africa) compared with super-regions with higher life expectancies (such as the high-income super-region), leading to a trend towards convergence in life expectancy across locations between now and 2050. At the super-region level, forecasted healthy life expectancy patterns were similar to those of life expectancies. Forecasts for the reference scenario found that health will improve in the coming decades, with all-cause age-standardised DALY rates decreasing in every GBD super-region. The total DALY burden measured in counts, however, will increase in every super-region, largely a function of population ageing and growth. We also forecasted that both DALY counts and age-standardised DALY rates will continue to shift from CMNNs to NCDs, with the most pronounced shifts occurring in sub-Saharan Africa (60·1% [95% UI 56·8–63·1] of DALYs were from CMNNs in 2022 compared with 35·8% [31·0–45·0] in 2050) and south Asia (31·7% [29·2–34·1] to 15·5% [13·7–17·5]). This shift is reflected in the leading global causes of DALYs, with the top four causes in 2050 being ischaemic heart disease, stroke, diabetes, and chronic obstructive pulmonary disease, compared with 2022, with ischaemic heart disease, neonatal disorders, stroke, and lower respiratory infections at the top. The global proportion of DALYs due to YLDs likewise increased from 33·8% (27·4–40·3) to 41·1% (33·9–48·1) from 2022 to 2050, demonstrating an important shift in overall disease burden towards morbidity and away from premature death. The largest shift of this kind was forecasted for sub-Saharan Africa, from 20·1% (15·6–25·3) of DALYs due to YLDs in 2022 to 35·6% (26·5–43·0) in 2050. In the assessment of alternative future scenarios, the combined effects of the scenarios (Safer Environment, Improved Childhood Nutrition and Vaccination, and Improved Behavioural and Metabolic Risks scenarios) demonstrated an important decrease in the global burden of DALYs in 2050 of 15·4% (13·5–17·5) compared with the reference scenario, with decreases across super-regions ranging from 10·4% (9·7–11·3) in the high-income super-region to 23·9% (20·7–27·3) in north Africa and the Middle East. The Safer Environment scenario had its largest decrease in sub-Saharan Africa (5·2% [3·5–6·8]), the Improved Behavioural and Metabolic Risks scenario in north Africa and the Middle East (23·2% [20·2–26·5]), and the Improved Nutrition and Vaccination scenario in sub-Saharan Africa (2·0% [–0·6 to 3·6]). Interpretation: Globally, life expectancy and age-standardised disease burden were forecasted to improve between 2022 and 2050, with the majority of the burden continuing to shift from CMNNs to NCDs. That said, continued progress on reducing the CMNN disease burden will be dependent on maintaining investment in and policy emphasis on CMNN disease prevention and treatment. Mostly due to growth and ageing of populations, the number of deaths and DALYs due to all causes combined will generally increase. By constructing alternative future scenarios wherein certain risk exposures are eliminated by 2050, we have shown that opportunities exist to substantially improve health outcomes in the future through concerted efforts to prevent exposure to well established risk factors and to expand access to key health interventions

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Background: Understanding the health consequences associated with exposure to risk factors is necessary to inform public health policy and practice. To systematically quantify the contributions of risk factor exposures to specific health outcomes, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 aims to provide comprehensive estimates of exposure levels, relative health risks, and attributable burden of disease for 88 risk factors in 204 countries and territories and 811 subnational locations, from 1990 to 2021. Methods: The GBD 2021 risk factor analysis used data from 54 561 total distinct sources to produce epidemiological estimates for 88 risk factors and their associated health outcomes for a total of 631 risk–outcome pairs. Pairs were included on the basis of data-driven determination of a risk–outcome association. Age-sex-location-year-specific estimates were generated at global, regional, and national levels. Our approach followed the comparative risk assessment framework predicated on a causal web of hierarchically organised, potentially combinative, modifiable risks. Relative risks (RRs) of a given outcome occurring as a function of risk factor exposure were estimated separately for each risk–outcome pair, and summary exposure values (SEVs), representing risk-weighted exposure prevalence, and theoretical minimum risk exposure levels (TMRELs) were estimated for each risk factor. These estimates were used to calculate the population attributable fraction (PAF; ie, the proportional change in health risk that would occur if exposure to a risk factor were reduced to the TMREL). The product of PAFs and disease burden associated with a given outcome, measured in disability-adjusted life-years (DALYs), yielded measures of attributable burden (ie, the proportion of total disease burden attributable to a particular risk factor or combination of risk factors). Adjustments for mediation were applied to account for relationships involving risk factors that act indirectly on outcomes via intermediate risks. Attributable burden estimates were stratified by Socio-demographic Index (SDI) quintile and presented as counts, age-standardised rates, and rankings. To complement estimates of RR and attributable burden, newly developed burden of proof risk function (BPRF) methods were applied to yield supplementary, conservative interpretations of risk–outcome associations based on the consistency of underlying evidence, accounting for unexplained heterogeneity between input data from different studies. Estimates reported represent the mean value across 500 draws from the estimate's distribution, with 95% uncertainty intervals (UIs) calculated as the 2·5th and 97·5th percentile values across the draws. Findings: Among the specific risk factors analysed for this study, particulate matter air pollution was the leading contributor to the global disease burden in 2021, contributing 8·0% (95% UI 6·7–9·4) of total DALYs, followed by high systolic blood pressure (SBP; 7·8% [6·4–9·2]), smoking (5·7% [4·7–6·8]), low birthweight and short gestation (5·6% [4·8–6·3]), and high fasting plasma glucose (FPG; 5·4% [4·8–6·0]). For younger demographics (ie, those aged 0–4 years and 5–14 years), risks such as low birthweight and short gestation and unsafe water, sanitation, and handwashing (WaSH) were among the leading risk factors, while for older age groups, metabolic risks such as high SBP, high body-mass index (BMI), high FPG, and high LDL cholesterol had a greater impact. From 2000 to 2021, there was an observable shift in global health challenges, marked by a decline in the number of all-age DALYs broadly attributable to behavioural risks (decrease of 20·7% [13·9–27·7]) and environmental and occupational risks (decrease of 22·0% [15·5–28·8]), coupled with a 49·4% (42·3–56·9) increase in DALYs attributable to metabolic risks, all reflecting ageing populations and changing lifestyles on a global scale. Age-standardised global DALY rates attributable to high BMI and high FPG rose considerably (15·7% [9·9–21·7] for high BMI and 7·9% [3·3–12·9] for high FPG) over this period, with exposure to these risks increasing annually at rates of 1·8% (1·6–1·9) for high BMI and 1·3% (1·1–1·5) for high FPG. By contrast, the global risk-attributable burden and exposure to many other risk factors declined, notably for risks such as child growth failure and unsafe water source, with age-standardised attributable DALYs decreasing by 71·5% (64·4–78·8) for child growth failure and 66·3% (60·2–72·0) for unsafe water source. We separated risk factors into three groups according to trajectory over time: those with a decreasing attributable burden, due largely to declining risk exposure (eg, diet high in trans-fat and household air pollution) but also to proportionally smaller child and youth populations (eg, child and maternal malnutrition); those for which the burden increased moderately in spite of declining risk exposure, due largely to population ageing (eg, smoking); and those for which the burden increased considerably due to both increasing risk exposure and population ageing (eg, ambient particulate matter air pollution, high BMI, high FPG, and high SBP). Interpretation: Substantial progress has been made in reducing the global disease burden attributable to a range of risk factors, particularly those related to maternal and child health, WaSH, and household air pollution. Maintaining efforts to minimise the impact of these risk factors, especially in low SDI locations, is necessary to sustain progress. Successes in moderating the smoking-related burden by reducing risk exposure highlight the need to advance policies that reduce exposure to other leading risk factors such as ambient particulate matter air pollution and high SBP. Troubling increases in high FPG, high BMI, and other risk factors related to obesity and metabolic syndrome indicate an urgent need to identify and implement interventions

Effect of buds removing and corm size on growth characteristics and yield of saffron (Crocus sativus L.)

The objectives of this research were investigated the effects of removal of lateral and main buds in different corm size on vegetative traits and yield of saffron. The research was conducted as factorial based on a randomized complete block design with three replications at the Research field of Faculty of Agriculture, Tarbiat Modares University in Tehran-Iran, during growing season of 2012-2013. The first factor was corm size with two levels of corm weight (2-4 and 6-8 g) and the second factor was buds removal with nine levels included without bud removal, remove all lateral buds, remove all buds except main buds and one lateral bud, remove all buds except main buds and two lateral buds, remove all buds except main buds and three lateral buds, remove all buds except one lateral bud, remove all buds except two lateral buds, remove all buds except three lateral buds, remove all buds except four lateral buds. In this research, vegetative traits in the first year and reproductive traits in the second year were investigated. The results showed that by removing main bud from corm leaf length and root length were decreased. Also, there was most root length by removing all lateral buds. Overall, the results showed that bud removal could be produce large corm but main bud should not eliminated. The most appropriate the number of buds that could be remaining is 4 large buds on saffron corm

Alteration of Flower Yield and Phytochemical Compounds of Saffron (<i>Crocus sativus</i> L.) by Application of Different Light Qualities and Growth Regulators

Saffron is the world’s most coveted spicy plant that has medicinal value. Currently, due to diverse types of difficulties in growing this plant outdoor, the tendency to produce it indoor has been increased. Optimized indoor conditions for growing saffron plants is not fully determined so far. This study was conducted to investigate the interactive effects of two plant growth regulators (PGRs), including gibberellic acid (GA3) and γ-aminobutyric acid (GABA) and four light recipes, including white, monochromatic blue, monochromatic red, and a combination of 50% red and 50% blue on the flower yield and phytochemical components (such as crocin, picrocrocin and safranal) in stigmas of indoor-grown saffron. The results showed that exogenous GABA application and combined red and blue LED lights enhanced the performance of saffron flowers in terms of the number of flowers (up to 1.97 per corm) as well as the fresh and dry weight of flowers and stigmas. In saffron, the concentration of three major secondary metabolites is of great importance since it determines its commercial, pharmaceutical quality. GABA induced saffron’s chemical ingredients toward the phytochemicals safranal (up to 5.03%) and picrocrocin (up to 15.8%), while GA3 induced them toward the carotenoid pigment crocin (up to 25.1%). In conclusion, the application of GABA with a combination of red and blue lights enhanced the production of high-quality stigmas and positively affected the yield of flowers in saffron plants

The Effect of hormone priming and corm weight on the yield of flowers and characteristics of daughter corms of saffron in the first year

Saffron is one of the most important crops and medicinal plants in Iran and plays an important role in non-oil exports of the country. Although Iran has the largest area under cultivation of saffron, its yield is low compared with global production. The main objective of this study is to investigate the yield of flowers and quantitative characteristics of daughter corms under the effects of application of plant growth regulators priming and two different corm sizes. A factorial experiment arrangement in RCBD with four replications was conducted, under the terms of pot at the College of Aburaihan-University of Tehran, Iran during 2015. Small (3-5g) and large (8-10g) mother corm sizes were hormonal priming by gibberelic acid (GA3), cytokinin (BA), auxin (IBA) with 250 ppm concentration and before cultivation. The start of flowering, number and flowers yield, fresh weight of flower, fresh and dry weight of stigma, number and weight of daughter corms per mother corms were measured. The results showed that in all traits except the start of flowering large corms weighing of 8 to 10 g were cultivated in comparison with small corms and this was significant at the 1% level. Application of cytokinins hormone in comparison with control for all traits except the start of flowering and weight of daughter corms showed a significant difference at 1%. Application of gibberellic acid hormone treatment also accelerated flowering. In addition, it increased the weight of daughter corms by 56% in large mother corms compared to control and this had a significant difference from control at 1%. Auxin (IBA) in the number of flowers had no significant difference with control and also in other traits, although IBA was better than control, with both BA and GA3 treatments had a significant difference. The results indicated that the use of large mother corms with hormonal priming with BA and GA3 will improve flower and corm yield in the first year

Effect of corm priming with salicylic acid and mother corm weight on flowering and qualitative characteristics of saffron stigma

Salicylic acid as a plant hormone plays an important role in regulating growth and physiological processes in plant. In order to study the effects of salicylic acid hormone and mother corm weight on saffron flowering properties, an experiment was conducted as factorial based on a randomized complete block design with three replications at the saffron research field of College of Aburaihan, University of Tehran during 2016-2017. The first factor consist of salicylic acid in three levels (Normal, priming with 1 and 2 mM concentrations (and second factor was weight of corm in two level that consist of small corm (3-5 gr) and large corm (8-10 gr). The results showed that the effect of corm weight on fresh weight of flower, Length of flower, fresh weight of stigma, length of stigma, fresh weight of pistil, length of pistil and qualitative characteristics of stigma were significant. The amount of these traits was higher in terms of the use of large mother’s corms. The effect of corm weight on dry weight of stigma was not significant. Interaction between salicylic acid and corm weight on all traits was not significant but the results of mean comparisons showed that the highest amount of fresh weight of flower (99.5 kg/ha), dry weight of stigma (1.45 kg/ha) and lowest days to emergence was 47 days after planting that related to salicylic acid in 2 mM. More amount of picrocrocin as a saffron flavor was related to salicylic acid in 1 mM. Crocin percentage in the priming treatment with 2 mM salicylic acid was higher than the other two levels; amount of safranal was high at 1mM. Totally, results of this experiment indicated that planting large mother’s corms with salicylic acid led to improvement of some quantitative and qualitative characteristics of saffron stigma

Contribution of Exogenous Proline to Abiotic Stresses Tolerance in Plants: A Review

Abiotic stresses are the major environmental factors that play a significant role in decreasing plant yield and production potential by influencing physiological, biochemical, and molecular processes. Abiotic stresses and global population growth have prompted scientists to use beneficial strategies to ensure food security. The use of organic compounds to improve tolerance to abiotic stresses has been considered for many years. For example, the application of potential external osmotic protective compounds such as proline is one of the approaches to counteract the adverse effects of abiotic stresses on plants. Proline level increases in plants in response to environmental stress. Proline accumulation is not just a signal of tension. Rather, according to research discussed in this article, this biomolecule improves plant resistance to abiotic stress by rising photosynthesis, enzymatic and non-enzymatic antioxidant activity, regulating osmolyte concentration, and sodium and potassium homeostasis. In this review, we discuss the biosynthesis, sensing, signaling, and transport of proline and its role in the development of various plant tissues, including seeds, floral components, and vegetative tissues. Further, the impacts of exogenous proline utilization under various non-living stresses such as drought, salinity, high and low temperatures, and heavy metals have been extensively studied. Numerous various studies have shown that exogenous proline can improve plant growth, yield, and stress tolerance under adverse environmental factors